AIM
CLB icon

Arcadia Investment Management’s Core Laboratories CLB Stock Holding History

Arcadia Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$883 – 317
2023
Q4 		$883 Hold
50
– – ﹤0.01% 308
2023
Q3 		$1.2K Hold
50
– – ﹤0.01% 313
2023
Q2 		$1.16K Hold
50
– – ﹤0.01% 331
2023
Q1 		$1.1K Hold
50
– – ﹤0.01% 343
2022
Q4 		$1.01K Hold
50
– – ﹤0.01% 339
2022
Q3 		$1K Hold
50
– – ﹤0.01% 272
2022
Q2 		$1K Hold
50
– – ﹤0.01% 281
2022
Q1 		$2K Hold
50
– – ﹤0.01% 275
2021
Q4 		$1K Sell
50
-2,090
-98% -$54.5K ﹤0.01% 283
2021
Q3 		$59K Buy
2,140
+1,564
+272% +$47.6K 0.01% 190
2021
Q2 		$22K Sell
576
-99
-15% -$3.55K ﹤0.01% 233
2021
Q1 		$19K Sell
675
-347
-34% -$11.9K ﹤0.01% 243
2020
Q4 		$27K Sell
1,022
-2,376
-70% -$48.5K 0.01% 213
2020
Q3 		$52K Sell
3,398
-750
-18% -$15.7K 0.01% 188
2020
Q2 		$84K Sell
4,148
-1,580
-28% -$28.3K 0.02% 144
2020
Q1 		$59K Sell
5,728
-1,585
-22% -$44.3K 0.02% 172
2019
Q4 		$275K Sell
7,313
-5,270
-42% -$237K 0.07% 111
2019
Q3 		$587K Sell
12,583
-1,425
-10% -$66.2K 0.16% 84
2019
Q2 		$732K Sell
14,008
-575
-4% -$33.7K 0.2% 80
2019
Q1 		$1M Sell
14,583
-1,430
-9% -$95.9K 0.29% 71
2018
Q4 		$955K Sell
16,013
-20,036
-56% -$1.73M 0.32% 70
2018
Q3 		$4.18M Sell
36,049
-119
-0.3% -$13.4K 1.1% 34
2018
Q2 		$4.57M Buy
36,168
+1,015
+3% +$124K 1.27% 31
2018
Q1 		$3.8M Sell
35,153
-999
-3% -$111K 1.07% 37
2017
Q4 		$3.96M Buy
36,152
+955
+3% +$95.3K 1.11% 36
2017
Q3 		$3.47M Sell
35,197
-3,450
-9% -$334K 1.06% 35
2017
Q2 		$3.91M Sell
38,647
-3,886
-9% -$419K 1.24% 29
2017
Q1 		$4.91M Sell
42,533
-856
-2% -$99.5K 1.55% 21
2016
Q4 		$5.21M Sell
43,389
-3,525
-8% -$390K 1.7% 16
2016
Q3 		$5.27M Sell
46,914
-2,637
-5% -$304K 1.75% 17
2016
Q2 		$6.14M Sell
49,551
-222
-0.4% -$26.8K 2% 10
2016
Q1 		$5.59M Sell
49,773
-2,440
-5% -$253K 1.84% 17
2015
Q4 		$5.68M Sell
52,213
-5,155
-9% -$590K 1.73% 19
2015
Q3 		$5.72M Sell
57,368
-6,010
-9% -$654K 1.75% 19
2015
Q2 		$7.23M Buy
63,378
+7,860
+14% +$953K 1.88% 17
2015
Q1 		$5.8M Sell
55,518
-276
-0.5% -$29.4K 1.63% 23
2014
Q4 		$6.71M Sell
55,794
-815
-1% -$107K 1.9% 23
2014
Q3 		$8.29M Buy
56,609
+1,325
+2% +$205K 2.49% 6
2014
Q2 		$9.24M Buy
55,284
+16,297
+42% +$2.9M 2.69% 5
2014
Q1 		$7.74M Sell
38,987
-7,910
-17% -$1.49M 2.26% 11
2013
Q4 		$8.96M Sell
46,897
-575
-1% -$107K 2.12% 14
2013
Q3 		$8.03M Buy
47,472
+370
+0.8% +$57.4K 2.09% 13
2013
Q2 		$7.14M Buy
+47,102
New +$6.67M 2.03% 15

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Arcadia Investment Management's CLB Position: Q1 2024 in Review

Arcadia Investment Management sold out of Core Laboratories (CLB) in Q1 2024, closing a stake of 50 shares — an estimated $883 sold.

Arcadia Investment Management first reported a position in CLB in Q2 2013 and held it in 43 quarters. The position peaked at $9.24M in Q2 2014. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.

  • Arcadia Investment Management reported no remaining Core Laboratories position as of Q1 2024 after selling out during the quarter.
  • Arcadia Investment Management sold 50 Core Laboratories shares in Q1 2024, an estimated $883.
  • Arcadia Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 43 quarters.
  • Arcadia Investment Management's Core Laboratories position peaked at $9.24M in Q2 2014.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.

Based on Arcadia Investment Management's 13F filing for Q1 2024, filed 23 Apr 2024.